×

img Acces sibility Controls

Research Projects Banner

Research Projects

Epigenomic and transcriptomic patterns in patients with common variable immunodeficiency: A whole genome sequencing based study.

Implementing Organization

Post Graduate Institute Of Medical Education And Research
Principal Investigator
Dr. Ankur Kumar Jindal
Post Graduate Institute Of Medical Education And Research
CO-Principal Investigator
Dr. Priyanka srivastava
Post Graduate Institute Of Medical Education And Research
CO-Principal Investigator
Dr. Amit Rawat
Post Graduate Institute Of Medical Education And Research
CO-Principal Investigator
Dr. saniya sharma
Post Graduate Institute Of Medical Education And Research
CO-Principal Investigator
Dr. Manpreet Dhaliwal
Post Graduate Institute Of Medical Education And Research

About

Common Variable Immunodeficiency (CVID) is a common primary immunodeficiency (PID) with variable clinical manifestations and age of onset. The etiology of CVID is also variable, with a large proportion of patients not having an identifiable genetic defect. Epigenetics plays an important role in the pathogenesis of the remaining 80% of cases, with DNA methylation being one potential epigenetic regulator. Age-specific alterations in the pattern of DNA methylation may play a significant role in the development of different stages of B cells. This study aims to identify DNA methylation patterns in patients with CVID at various stages of B cell development and functional characterization through RNA sequencing. Thirty patients fulfilling the European society of Immune Deficiencies (EsID) 2014 criteria for diagnosis and 30 unrelated, age, and gender-matched healthy controls will be included. Peripheral blood mononuclear cells (PBMCs) will be isolated from patient samples, and staining of Naïve, unswitched memory, and switched memory B cells will be done using FACs grade antibodies. DNA will be subjected to bisulfite treatment followed by high throughput sequencing of bisulfite treated DNA. Differentially methylated CVID relevant genes will be validated through targeted bisufite sequencing. CpG specific primers will be designed through bisulfite primer seeker, and bisulfite treated DNA from specific B cell subsets will be amplified using regular PCR. RNA will be extracted from sorted B cells using RNA purification kit, and an RNA library will be prepared following the Illumina Trueseq protocol.
Funding Organization
Funding Organization
Science and Engineering Research Board (SERB), New Delhi
Anusandhan National Research Foundation (ANRF)
Quick Information
Area of Research
Life Sciences & Biotechnology
Start Year
2023
End Year
2026
Sanction Amount
₹ 67.76 L
Status
Ongoing
Output
No. of Research Paper
00
Technologies (If Any)
00
No. of PhD Produced
N/A
Startup (If Any)
00
No. of Patents
Filed :00
Grant :00
arrowtop